Last week was argument week at the Federal Circuit, which as usual meant the Court issued several Rule 36 affirmances and short non-precedential decisions. But tucked in between those was at least one case—a Hatch-Waxman...more
11/11/2020
/ Abbreviated New Drug Application (ANDA) ,
Generic Drugs ,
Hatch-Waxman ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Precedential Opinion ,
Principal Place of Business ,
Rule 36 ,
Venue
With yesterday’s House Judiciary Committee vote, there are now competing, and in some respects significantly different, patent reform proposals under serious consideration in the House and the Senate. Among the most important...more
7/28/2015
/ Fee-Shifting ,
Hedge Funds ,
Inter Partes Review (IPR) Proceeding ,
Patent Act ,
Patent Infringement ,
Patent Reform ,
Patent Trial and Appeal Board ,
Patent Trolls ,
Patents ,
Post-Grant Review ,
Proposed Legislation ,
USPTO ,
Venue
Yesterday, the Senate Judiciary Committee voted 16-4 to send an amended version of S. 1137, the Protecting American Talent and Entrepreneurship (PATENT) Act, to the full Senate for debate. The PATENT Act is this year’s...more
This year’s debate on federal patent reform has begun in earnest. Last Friday, the White House expressed its support for the leading Senate bill, the Protecting American Talent and Entrepreneurship (PATENT) Act (S. 1137), and...more
Yesterday, Senate Judiciary Committee Chairman Patrick Leahy (D-VT) announced that he was taking his patent reform bill off the agenda. As a result, it is unlikely that Congress will pass patent reform legislation this...more
Patent reform legislation has garnered much national attention over the past year, as Congress has introduced numerous proposals to curb perceived litigation abuse by patent trolls. (See our previous alert here.) The House of...more